Clinical Trials
Discover the future of medicine today. Yale Medicine currently offers 687 active clinical trials across our hospitals and care centers, providing our patients with early access to many of the world’s most advanced therapies. Yale Center for Clinical Investigation (YCCI) supports, coordinates, and oversees clinical trials, ensuring the safety of trial volunteers.
For more information about cancer-related trials, call us at 203-785-5702. For all other trials, call 877-978-8343.
25 Results
A Phase I/II Trial of Reduced Intensity Conditioning and Familial HLA-Mismatched Bone Marrow Transplantation in Children With Non-Malignant Disorders
- Leukemia & Hematologic Cancers
- Pediatric Cancers
- Gender:All Genders
- Age:21 years and younger
Impact of Hypoglycemia on Brain Ketone and Neurotransmitter Metabolism in Type 1 DM
- Diabetes
- Endocrine System
- Brain, Spinal Cord & Nervous System
- Gender:All Genders
- Age:18 years and older
A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis (NATiV3)
- Liver
- Gender:All Genders
- Age:18 years and older
A Two-Part Open-Label Study of REGV131-LNP1265, A CRISPR/Cas9 Based Coagulation Factor IX Gene Insertion Therapy in Participants With Hemophilia B
A Phase 1/2 Study to Investigate the Safety, Pharmacokinetics, and Efficacy of CRB-701, an Antibody-drug Conjugate Targeting Nectin-4, in Patients With Advanced Solid Tumors
- Prostate Cancer
- Bladder Cancer
A Phase 1/2 Platform Study to Evaluate the Safety and Efficacy of Investigational Agents in Pediatric and Young Adult Participants with Hematologic Malignancies or Solid Tumors
- Sarcoma Cancers
- Lymphoma
- Phase 1 Cancers
- Pediatric Cancers
A Phase 1 Dose-Escalation and Expansion Study Evaluating the Safety, Efficacy, and Pharmacokinetics of EVOLVE104 in Subjects With Advanced Urothelial and Squamous Cell Carcinomas
- Colorectal Cancer
- Stomach & Esophagus
- Head & Neck Cancers
- Lung Cancer
- Gynecological Cancers
- Male Genital Cancers
- Bladder Cancer
- Phase 1 Cancers
Targeted Treatment for Advanced Non-Small Cell Lung Cancer that has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Lung Cancer
A Phase 1, First-in-Human Study of CUSP06, a Cadherin-6 (CDH6)-Directed Antibody-Drug Conjugate, in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
- Phase 1 Cancers
DSB2455-001: Phase Ia/Ib Open Label, Multi-Centre Dose Escalation Study with Expansion Cohorts to Assess the Safety, Tolerability, and Activity of DSB2455 as Monotherapy in Participants with Advanced Malignancies (WCG local)
- Phase 1 Cancers
1-10 of 25 Results